Background: Current guidelines and most experts recommend pharmacologic venous thromboembolism (VTE) prophylaxis for patients hospitalized with an acute inflammatory bowel disease (IBD) exacerbation.  Quality measures of physician performance further expand this mandate to include patients with a diagnosis of IBD who are hospitalized for any reason. We sought to assess the risk of VTE in [...]